- Home
- / DotBio
DotBio
Total Funding
$2.5 M
DotBio Summary
Company Summary
- Overview
- DotBio is a biopharmaceutical company specializing in domain antibody therapies. It focuses on the development of immuno-oncology drugs based on humanized domain antibodies using its proprietary DotBody technology.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Singapore, SG | view all locations
- Website
- https://www.dotbio.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Singapore HQ
Singapore
1 Research Link
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026